The Netherlands Cancer Institute

SEP 11, 2026 · PHASE 2 TRIAL

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

ClinicalTrials.gov

This is an active Phase 2 interventional trial with no results reported; the registry record describes planned enrollment and endpoints only, not outcomes.

SEP 8, 2026 · PHASE 2 TRIAL

RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer

ClinicalTrials.gov

This is an unstarted Phase 2 interventional trial with no posted results; it is a study design and rationale only, representing early-stage exploration of immunotherapy monotherapy in a selected population.

AUG 11, 2026 · PHASE 1 TRIAL

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

ClinicalTrials.gov

Phase 1 diagnostic imaging study in early recruitment with no results posted; designed to assess tracer accumulation and feasibility of detecting HER2 phenotype differences.